Jun 23, 2016
Thesis Defense
Synergistic Anti-Tumor Immune Response to Combination Immunotherapy Consisting of Anti-Tumor Antibodies, Extended Half-Life Interleukin-2, and Other Immunomodulatory Agents
Eric Zhu (Wittrup Group)
2:00 p.m., 76-156